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Introduction
Lactate dehydrogenase (LDH) is a ubiquitous enzyme, which 
has the pivotal role in the clinical diagnosis of many disease 
processes. LDH is known to catalyze the oxidative conversion 
of the substrate pyruvate to lactate and has been used as an 
infl ammatory marker. LDH is routinely present in the cytoplasm 
of the cell that gets released into the extracellular environment 
upon cellular lysis and cell death.[1] Thus, LDH represents a 
marker to cell death and tissue breakdown and its raised level 
often signifi es a disease process.
LDH Isolation and Activity
LDH displays diﬀ erent isoenzyme profi les in diﬀ erent body fl uids 
including serum, saliva, cerebrospinal fl uid, etc. It is observed 
LDH-1 and LDH-2, which predominate in plasma, could be 
detected to only a limited extent in saliva secreted under resting 
conditions, whereas LDH-1 in saliva could barely be detected 
under stimulated conditions. Isoenzymes LDH-4 and LDH-5 
were found to predominate in saliva, with higher specifi c activity 
than in plasma.[2] LDH is a ubiquitous enzyme that plays an 
important role in the clinical diagnosis of pathologic processes. 
Monitoring of LDH total enzyme activity and isoenzyme profi les 
in plasma is considered as an important clinical tool for detecting 
the nature and severity of various pathologies.[3]
Approximately, 75% of the LDH in the whole saliva does not 
originate from the major salivary glands. Stimulating the major 
salivary glands and consequently increasing their secretions 
and their relative volumetric part in whole saliva, resulting in 
a profound diluting eﬀ ect of the whole salivary LDH, with a 
76% reduction of total activity (P < 0.01). This adds credence 
to the conclusion that the major source for whole-saliva LDH 
is non-glandular.[4] LDH activity in the whole saliva is a better 
indicator and a useful biochemical marker for health and 
disease.[5] De La Peña et al., 2004 studied the enzyme activity 
in saliva at a diﬀ erent temperature to establish a standardized 
protocol for isolation, quantifi cation, and storage of the 
enzyme. It was found that salivary LDH without any additives 
was suitable to be stored at 4°C for 3 months. At −20°C, they 
found a signifi cant decrease in the LDH activity after only 
30 min of storage.[6]
Polyethylene glycol can be used as a preservative for LDH 
storage which represents the best additive for salivary LDH 
storage at all temperatures whereas; ethylenediaminetetraacetic 
acid is suitable only at room temperature for a week.[7]
LDH and the Disease Process
Raised LDH activity in saliva is often related to tissue 
infl ammation and damage to oral tissues, commonly caused 
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by gingivitis and periodontitis. Numabe et al., 2004 stated that 
LDH activity was reduced after an individual undergoes the 
periodontal therapy (with signifi cant reduction with just phase 1 
therapy). Thus, LDH in saliva has been a suitable indicator and 
diagnostic tool to assess the periodontal health.[8]
Todorovic et al., 2006 in their study observed that the 
activities of LDH enzyme in saliva which was signifi cantly 
increased in the patients with periodontal disease in comparison 
to those healthy patients.[9]
Furthermore screening of oral lichen planus can be 
performed by measuring salivary LDH, which may be a feasible, 
simple, and convenient approach that does not require expert 
examiners.[10,11]
LDH and Oral Cancer
Oral cancer is the neoplastic process that usually begins with 
normal epithelium progressing through hyperplasia to dysplasia 
to carcinoma in situ and invasive carcinoma. Early diagnosis 
improves the overall survival rate and prognosis which is 
determined by the ability of oral health care professionals to 
detect the relevant potentially malignant lesions or cancerous 
lesions at their earliest or most incipient stage.
Such a goal could be achieved by increasing public awareness 
about the importance of regular oral screening or case fi nding 
examinations to identify the small, otherwise asymptomatic 
cancers, and pre-cancers.
Though immunohistochemical procedures have become 
more popular, histochemical techniques are still used in the 
diagnosis of tumors. Using enzyme-histochemistry, metabolic 
activities of malignant and premalignant cells diﬀ er from those 
of the tissue of origin can be demonstrated. Both qualitative, 
i.e., presence, raised or lowered activity, changes in is enzyme 
pattern, and quantitative evaluation is possible. One fundamental 
metabolic change in the many premalignant and malignant cells 
is a shift from predominantly aerobic respiration to anaerobic 
glycolysis.[12,13]
Shpitzer et al., 2007 conducted a comprehensive salivary 
analysis to evaluate the biochemical parameters as potential 
markers in the diagnosis of oral squamous cell carcinoma 
(OSCC); it was found these salivary markers including LDH was 
signifi cantly higher in the patients with OSCC compared to the 
control group.[14]
Similar fi ndings in a study by Nagler et al., 2001 showed 
a profound increase in this enzyme profi le (salivary LDH) 
which is mainly derived from the exfoliated epithelial cells (in 
this case OSCC cells) which may represent a general salivary 
marker of the diseased oral mucosa. As a further interest the 
author also suggested future studies to be developed in order to 
establish a correlation between the level of salivary LDH and the 
aggressiveness of oral OSCC lesion, as the mitotic rate of more 
aggressive lesions is higher, and thus the salivary LDH may also 
be expected to increase.[15]
LDH and Tumor Diff erentiation
Squamous cell carcinoma usually exhibits a heterogeneous cell 
population with a diﬀ erence in the degree of diﬀ erentiation. As 
the presence of metastases is highly correlated with survival, 
histopathologic grading of tumors has therefore been used for 
many years to predict the outcome of a tumor, although with 
varying prognostic value.[16]
Several studies related to tumor diﬀ erentiation and the levels 
of the enzyme activity in serum have been reported.
Giatromanolaki et al., 2000 in their study of 76 patients with 
lung cancers observed an overexpression of LDH activity in 
serum in the advanced cancers.
Thus concluded expression of this biochemical marker in 
serum can predict the aggressiveness of the tumor and thus the 
prognosis.[17]
Similar studies by Mall et al., 2002 revealed serum LDH could 
be correlated to the advanced stages of small cell cancers of the 
lungs, similar fi ndings have been reported in ovarian cancers by 
Yüce et al., 2001.[18,19]
Poorly diﬀ erentiated head and neck cancers have also 
demonstrated high LDH levels suggesting a correlation between 
LDH levels and tumor diﬀ erentiation.[20]
Conclusion
LDH, a metabolic enzyme represent a disease indicator in 
several systemic conditions including myocardial infarction, liver 
disease, malignancies, etc. In particular, salivary LDH is a marker 
of oral health and tissue integrity. Its raised levels in saliva[21] are 
thus attributed to cell death and tissue breakdown in terms of 
periodontitis, carcinoma, and other mucosal conditions with 
tissue destruction. Thus, in future, the salivary LDH estimation 
can evolve as a non-invasive technique for routine screening in 
assessing oral diseases.
References
 1. Gandolfo S, Pentenero M, Broccoletti R, Pagano M, Carrozzo M, 
Scully C. Toluidine blue uptake in potentially malignant oral 
lesions in vivo: Clinical and histological assessment. Oral Oncol 
2006;42:89-95.
2. Gutteridge JM, Rowley DA, Halliwell B. Superoxide 
dependent formation of hydroxyl radicals in the presence 
of iron salts. Detection of free iron in biological systems by 
using bleomycin-dependent degradation of DNA. Biochem J 
1981;199:263-5.
3. Zappacosta B, Persichilli S, Mordente A, Minucci A, Lazzaro D, 
Meucci E, et al. Inhibition of salivary enzymes by cigarette smoke 
and the protective role of glutathione. Hum Exp Toxicol 
2002;21:7-11.
4. Musumeci V, Cherubini P, Zuppi C, Zappacosta B, Ghirlanda G, 
Di Salvo S. Aminotransferases and lactate dehydrogenase in 
saliva of diabetic patients. J Oral Pathol Med 1993;22:73-6.
5. De La Peña VA, Diz Dios P, Tojo Sierra R. Relationship between 
Lokesh and Jayanthi Lactate dehydrogenase in oral health and disease
3
lactate dehydrogenase activity in saliva and oral health status. 
Arch Oral Biol 2007;52:911-5.
6. Alonso de la Peña V, Diz Dios P, Lojo Rocamonde S, 
Tojo Sierra R, Rodríguez-Segade S. A standardised protocol for 
the quantifi cation of lactate dehydrogenase activity in saliva. 
Arch Oral Biol 2004;49:23-7.
7. Rohaya MA, Sahidan S, Zaidah ZA, Fahrul Zaman A, 
Nuraliza AW, Shahrul Hisham ZA. Stability of human 
salivary lactate dehydrogenase in the presence of 
ethylenediaminetetraacetic acid, glycerol and polyethylene 
glycol at various temperatures: Preliminary study. J Biol Sci 
2010;10:520-5.
8. Numabe Y, Hisano A, Kamoi K, Yoshie H, Ito K, Kurihara H. 
Analysis of saliva for periodontal diagnosis and monitoring. 
Periodontology 2004;40:115-9.
9. Todorovic T, Dozic I, Vicente-Barrero M, Ljuskovic B, Pejovic J, 
Marjanovic M, et al. Salivary enzymes and periodontal disease. 
Med Oral Patol Oral Cir Bucal 2006;11:E115-9.
10. Nagler RM, Hershkovich O, Lischinsky S, Diamond E, 
Reznick AZ. Saliva analysis in the clinical setting: Revisiting an 
underused diagnostic tool. J Investig Med 2002;50:214-25.
11. Chen YW, Lin JS, Wu CH, Lui MT, Kao SY, Fong Y. Application 
of in vivo stain of methylene blue as a diagnostic aid in the early 
detection and screening of oral squamous cell carcinoma and 
precancer lesions. J Chin Med Assoc 2007;70:497-503.
12. Vuotila T, Ylikontiola L, Sorsa T, Luoto H, Hanemaaijer R, 
Salo T, et al. Th e relationship between MMPs and pH in whole 
saliva of radiated head and neck cancer patients. J Oral Pathol 
Med 2002;31:329-38.
13. Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, et al. 
Potential biomarkers in saliva for oral squamous cell carcinoma. 
Oral Oncol 2010;46:226-31.
14. Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive 
salivary analysis for oral cancer diagnosis. J  Cancer Res Clin 
Oncol 2007;133:613-7.
15. Nagler RM, Lischinsky S, Diamond E, Klein I, Reznick AZ. New 
insights into salivary lactate dehydrogenase of human subjects. 
J Lab Clin Med 2001;137:363-9.
16. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. 
New malignancy grading is a better prognostic indicator than 
Broders’ grading in oral squamous cell carcinomas. J  Oral 
Pathol Med 1989;18:432-7.
17. Giatromanolaki A, Koukourakis MI, Sivridis E, O’Byrne K, 
Cox G, Th orpe PE, et al. Coexpression of MUC1 glycoprotein 
with multiple angiogenic factors in non-small cell lung cancer 
suggests coactivation of angiogenic and migration pathways. 
Clin Cancer Res 2000;6:1917-21.
18. Mall JW, Schwenk W, Philipp AW, Meyer-Kipker C, Mall W, 
Muller J, et al. Serum vascular endothelial growth factor levels 
correlate better with tumour stage in small cell lung cancer than 
albumin, neuron-specifi c enolase or lactate dehydrogenase.
Respirology 2002;7:99-102.
19. Yüce K, Baykal C, Genç C, Al A, Ayhan A. Diagnostic 
and prognostic value of serum and peritoneal fl uid lactate 
dehydrogenase in epithelial ovarian cancer. Eur J Gynaecol 
Oncol 2001;22:228-32.
20. Ross CD, Gomaa MA, Gillies E, Juengel R, Medina JE. 
Tumor grade, microvessel density, and activities of malate 
dehydrogenase, lactate dehydrogenase, and hexokinase in 
squamous cell carcinoma. Otolaryngol Head Neck Surg 
2000;122:195-200.
21. Lokesh K, Jayanthi K. Saliva: A mirror to health. Int J Contemp 
Dent Med Rev 2015;2015:Article ID: 030715, 2015. doi: 
10.15713/ins.ijcdmr.84. 
